Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Surface Oncology Inc (SURF)
NASDAQ:SURF
Surface Oncology (SURF) Stock Price & Analysis
892 Followers
SURF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.56 - $2.15
Previous Close$0.79
Volume23.30K
Average Volume (3M)207.88K
Market Cap
$50.42M
Enterprise Value$3.20M
Total Cash (Recent Filing)$102.06M
Total Debt (Recent Filing)$55.46M
Price to Earnings (P/E)-0.5
Beta1.80
Next Earnings
Aug 15, 2023EPS Estimate
-$0.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.53
Shares Outstanding39,906,066
10 Day Avg. Volume329,372
30 Day Avg. Volume207,882
Standard Deviation0.25
R-Squared0.13
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.11
Enterprise Value/Ebitda-0.04
Forecast
1Y Price Target
$5.25Price Target Upside560.38% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Surface Oncology News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SURF FAQ
What was Surface Oncology Inc’s price range in the past 12 months?
Surface Oncology Inc lowest stock price was $0.56 and its highest was $2.15 in the past 12 months.
What is Surface Oncology Inc’s market cap?
Currently, no data Available
When is Surface Oncology Inc’s upcoming earnings report date?
Surface Oncology Inc’s upcoming earnings report date is Aug 15, 2023 which is in 75 days.
How were Surface Oncology Inc’s earnings last quarter?
Surface Oncology Inc released its earnings results on May 04, 2023. The company reported -$0.33 earnings per share for the quarter, beating the consensus estimate of -$0.35 by $0.02.
Is Surface Oncology Inc overvalued?
According to Wall Street analysts Surface Oncology Inc’s price is currently Undervalued.
Does Surface Oncology Inc pay dividends?
Surface Oncology Inc does not currently pay dividends.
What is Surface Oncology Inc’s EPS estimate?
Surface Oncology Inc’s EPS estimate is -$0.33.
How many shares outstanding does Surface Oncology Inc have?
Surface Oncology Inc has 60,716,873 shares outstanding.
What happened to Surface Oncology Inc’s price movement after its last earnings report?
Surface Oncology Inc reported an EPS of -$0.33 in its last earnings report, beating expectations of -$0.35. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Surface Oncology Inc?
Among the largest hedge funds holding Surface Oncology Inc’s share is ARK Investment Management LLC. It holds Surface Oncology Inc’s shares valued at 4M.
---
Surface Oncology Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5.25 (560.38% Upside)
$5.25 (560.38% Upside)
Hedge Fund Trend
Decreased
By 71.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 3.6%
Last 30 Days ▲ 3.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.56%
12-Months-Change
Fundamentals
Return on Equity
-80.36%
Trailing 12-Months
Asset Growth
-37.06%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Surface Oncology Inc
Surface Oncology, Inc. is a clinical-stage immuno-oncology company, which focuses on biological pathways critical to the immunosuppressive tumor microenvironment and the development of next-generation cancer therapies. The company was founded by David S. Grayzel in 2014 and is headquartered in Cambridge, MA.
---
Top 5 ETFs holding SURF
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold SURF. The ETFs are listed according to market value of SURF within the ETF
---
---